Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  'cancer drug'
Latest

European regulators have good news for Amgen on cancer drugs

By   /  Friday, September 25th, 2015  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on European regulators have good news for Amgen on cancer drugs

One of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →

Read More →